Co-culture of 3D tumor spheroids with fibroblasts as a model for epithelial-mesenchymal transition in vitro

Experimental Cell Research

Volumn 335, Issue 2, 2015, Pages 187-196

  Kim, Sun Ah ^a   Lee, Eun Kyung ^a   Kuh, Hyo Jeong ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

3D culture; Cancer associated fibroblasts (CAFs); Colorectal cancer (CRC); Epithelial mesenchymal transition (EMT); Proximity co culture; Tumor spheroids (TS)

Indexed keywords

BETA CATENIN; COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; LAMININ; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VASCULOTROPIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FIBROBLAST; HT 29 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR SPHEROID; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL MOTION; DRUG RESISTANCE; EXTRACELLULAR MATRIX; METABOLISM; MULTICELLULAR SPHEROID; PHYSIOLOGY;

ANIMALS; CELL MOVEMENT; COCULTURE TECHNIQUES; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FEMALE; FIBROBLASTS; HT29 CELLS; HUMANS; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; SPHEROIDS, CELLULAR; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84937637735     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2015.05.016     Document Type: Article

References (42)

1. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
2. van Zijl F., Mair M., Csiszar A., Schneller D., Zulehner G., Huber H., Eferl R., Beug H., Dolznig H., Mikulits W. Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene 2009, 28:4022-4033.
3. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 2009, 9:265-273.
4. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak M., Brisken C., Yang J., Weinberg R.A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
5. Singh A., Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010, 29:4741-4751.
6. Voulgari A., Pintzas A. Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim. Biophys. Acta 2009, 1796:75-90.
7. Sharma S.V., Lee D.Y., Li B., Quinlan M.P., Takahashi F., Maheswaran S., McDermott U., Azizian N., Zou L., Fischbach M.A., Wong K.K., Brandstetter K., Wittner B., Ramaswamy S., Classon M., Settleman J. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 2010, 141:69-80.
8. Kim S., Chin J., Lee H., Byun Y., Park K. In vivo tumor targeting imaging of cyclic RGD-modified heparin derivative to αvβ3-integrin expressing tumor. J. Pharm. Investig. 2012, 42:9-14.
9. Yu Y., Xiao C.H., Tan L.D., Wang Q.S., Li X.Q., Feng Y.M. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-beta signalling. Br. J. Cancer 2014, 110:724-732.
10. Choe C., Shin Y.S., Kim S.H., Jeon M.J., Choi S.J., Lee J., Kim J. Tumor-stromal interactions with direct cell contacts enhance motility of non-small cell lung cancer cells through the hedgehog signaling pathway. Anticancer Res. 2013, 33:3715-3723.
11. Kirkland S.C. Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells. Br. J. Cancer 2009, 101:320-326.
12. Gallardo-Perez J.C., Rivero-Segura N.A., Marin-Hernandez A., Moreno-Sanchez R., Rodriguez-Enriquez S. GPI/AMF inhibition blocks the development of the metastatic phenotype of mature multi-cellular tumor spheroids. Biochim. Biophys. Acta 2014, 1843:1043-1053.
13. Kim S.H., Choi S.J., Kim Y.C., Kuh H.J. Anti-tumor activity of noble indirubin derivatives in human solid tumor models in vitro. Arch. Pharm. Res. 2009, 32:915-922.
14. Yeon S.E., No da Y., Lee S.H., Nam S.W., Oh I.H., Lee J., Kuh H.J. Application of concave microwells to pancreatic tumor spheroids enabling anticancer drug evaluation in a clinically relevant drug resistance model. PLoS One 2013, 8:e73345.
15. Amann A., Zwierzina M., Gamerith G., Bitsche M., Huber J.M., Vogel G.F., Blumer M., Koeck S., Pechriggl E.J., Kelm J.M., Hilbe W., Zwierzina H. Development of an innovative 3D cell culture system to study tumour-stroma interactions in non-small cell lung cancer cells. PLoS One 2014, 9:e92511.
16. Kalluri R., Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Investig. 2003, 112:1776-1784.
17. Maller O., DuFort C.C., Weaver V.M. YAP forces fibroblasts to feel the tension. Nat. Cell Biol. 2013, 15:570-572.
18. Costea D.E., Hills A., Osman A.H., Thurlow J., Kalna G., Huang X., Pena Murillo C., Parajuli H., Suliman S., Kulasekara K.K., Johannessen A.C., Partridge M. Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma. Cancer Res. 2013, 73:3888-3901.
19. Wipff P.J., Hinz B. Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship. Eur. J. Cell Biol. 2008, 87:601-615.
20. Jenkins G. The role of proteases in transforming growth factor-beta activation. Int. J. Biochem. Cell Biol. 2008, 40:1068-1078.
21. Giampieri S., Manning C., Hooper S., Jones L., Hill C.S., Sahai E. Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat. Cell Biol. 2009, 11:1287-1296.
22. Chung H., Ramachandran R., Hollenberg M.D., Muruve D.A. Proteinase-activated receptor-2 transactivation of epidermal growth factor receptor and transforming growth factor-beta receptor signaling pathways contributes to renal fibrosis. J. Biol. Chem. 2013, 288:37319-37331.
23. Loeffler M., Kruger J.A., Niethammer A.G., Reisfeld R.A. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J. Clin. Investig. 2006, 116:1955-1962.
24. Brabletz T., Spaderna S., Kolb J., Hlubek F., Faller G., Bruns C.J., Jung A., Nentwich J., Duluc I., Domon-Dell C., Kirchner T., Freund J.N. Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: an active role for the tumor environment in malignant tumor progression. Cancer Res. 2004, 64:6973-6977.
25. Islam S.S., Mokhtari R.B., El Hout Y., Azadi M.A., Alauddin M., Yeger H., Farhat W.A. TGF-beta1 induces EMT reprogramming of porcine bladder urothelial cells into collagen producing fibroblasts-like cells in a Smad2/Smad3-dependent manner. J. Cell Commun. Signal. 2014, 8:39-58.
26. Nelson W.J., Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004, 303:1483-1487.
27. Torres S., Bartolome R.A., Mendes M., Barderas R., Fernandez-Acenero M.J., Pelaez-Garcia A., Rena C., Lopez-Lucendo M., Villar-Vazquez R., Herreros A.G., Bonilla F., Casal J.I. Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signature and prognostic markers of colorectal cancer. Clin. Cancer Res. 2013, 19:6006-6019.
28. Mazzoccoli G., Pazienza V., Panza A., Valvano M.R., Benegiamo G., Vinciguerra M., Andriulli A., Piepoli A. ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer. J. Cancer Res. Clin. Oncol. 2012, 138:501-511.
29. Kantola T., Vayrynen J.P., Klintrup K., Makela J., Karppinen S.M., Pihlajaniemi T., Autio-Harmainen H., Karttunen T.J., Makinen M.J., Tuomisto A. Serum endostatin levels are elevated in colorectal cancer and correlated with invasion and systemic inflammatory markers. Br. J. Cancer 2014, 111:1605-1613.
30. Kahlert C., Bandapalli O.R., Schirmacher P., Weitz J., Brand K. Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer. Anticancer Res. 2008, 28:1459-1465.
31. Dittmer J., Leyh B. The impact of tumor stroma on drug response in breast cancer. Semin. Cancer Biol. 2015, 31:3-15.
32. Paraiso K.H., Smalley K.S. Fibroblast-mediated drug resistance in cancer. Biochem. Pharmacol. 2013, 85:1033-1041.
33. Netti P.A., Berk D.A., Swartz M.A., Grodzinsky A.J., Jain R.K. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res. 2000, 60:2497-2503.
34. Aoudjit F., Vuori K. Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells. Oncogene 2001, 20:4995-5004.
35. Pontiggia O., Sampayo R., Raffo D., Motter A., Xu R., Bissell M.J., Joffe E.B., Simian M. The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through beta1 integrin. Breast Cancer Res. Treat. 2012, 133:459-471.
36. Straussman R., Morikawa T., Shee K., Barzily-Rokni M., Qian Z.R., Du J., Davis A., Mongare M.M., Gould J., Frederick D.T., Cooper Z.A., Chapman P.B., Ribas A., Lo R.S., Flaherty K.T., Ogino S., Wargo J.A., Golub T.R. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 2012, 487:500-504.
37. Yao Z., Fenoglio S., Gao D.C., Camiolo M., Stiles B., Lindsted T., Schlederer M., Johns C., Altorki N., Mittal V., Kenner L., Sordella R. TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer. Proc. Natl. Acad. Sci. USA 2010, 107:15535-15540.
38. Eckermann C.W., Lehle K., Schmid S.A., Wheatley D.N., Kunz-Schughart L.A. Characterization and modulation of fibroblast/endothelial cell co-cultures for the in vitro preformation of three-dimensional tubular networks. Cell Biol. Int. 2011, 35:1097-1110.
39. Folkins C., Man S., Xu P., Shaked Y., Hicklin D.J., Kerbel R.S. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. Cancer Res. 2007, 67:3560-3564.
40. Sharma N., He Q., Sharma R.P. Augmented fumonisin B1 toxicity in co-cultures: evidence for crosstalk between macrophages and non-parenchymatous liver epithelial cells involving proinflammatory cytokines. Toxicology 2004, 203:239-251.
41. Rama-Esendagli D., Esendagli G., Yilmaz G., Guc D. Spheroid formation and invasion capacity are differentially influenced by co-cultures of fibroblast and macrophage cells in breast cancer. Mol. Biol. Rep. 2014, 41:2885-2892.
42. Go A., Ryu Y.K., Lee J.W., Moon E.Y. Cell motility is decreased in macrophages activated by cancer cell-conditioned medium. Biomol. Ther. 2013, 21:481-486.